160 related articles for article (PubMed ID: 19225410)
1. TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies.
Olivé M; Janué A; Moreno D; Gámez J; Torrejón-Escribano B; Ferrer I
J Neuropathol Exp Neurol; 2009 Mar; 68(3):262-73. PubMed ID: 19225410
[TBL] [Abstract][Full Text] [Related]
2. Expression of mutant ubiquitin (UBB+1) and p62 in myotilinopathies and desminopathies.
Olivé M; van Leeuwen FW; Janué A; Moreno D; Torrejón-Escribano B; Ferrer I
Neuropathol Appl Neurobiol; 2008 Feb; 34(1):76-87. PubMed ID: 17931355
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia.
Weihl CC; Temiz P; Miller SE; Watts G; Smith C; Forman M; Hanson PI; Kimonis V; Pestronk A
J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1186-9. PubMed ID: 18796596
[TBL] [Abstract][Full Text] [Related]
4. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.
Neumann M; Mackenzie IR; Cairns NJ; Boyer PJ; Markesbery WR; Smith CD; Taylor JP; Kretzschmar HA; Kimonis VE; Forman MS
J Neuropathol Exp Neurol; 2007 Feb; 66(2):152-7. PubMed ID: 17279000
[TBL] [Abstract][Full Text] [Related]
5. Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions.
Tawara N; Yamashita S; Kawakami K; Kurashige T; Zhang Z; Tasaki M; Yamamoto Y; Nishikami T; Doki T; Zhang X; Matsuo Y; Kimura E; Tawara A; Maeda Y; Hauschka SD; Maruyama H; Ando Y
Exp Neurol; 2018 Nov; 309():169-180. PubMed ID: 30130494
[TBL] [Abstract][Full Text] [Related]
6. Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.
Pinkus JL; Amato AA; Taylor JP; Greenberg SA
Neuromuscul Disord; 2014 Jul; 24(7):611-6. PubMed ID: 24857366
[TBL] [Abstract][Full Text] [Related]
7. Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis.
Yamashita S; Kimura E; Tawara N; Sakaguchi H; Nakama T; Maeda Y; Hirano T; Uchino M; Ando Y
Neuropathol Appl Neurobiol; 2013 Jun; 39(4):406-16. PubMed ID: 22860700
[TBL] [Abstract][Full Text] [Related]
8. Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and inclusion body myositis.
Ferrer I; Carmona M; Blanco R; Moreno D; Torrejón-Escribano B; Olivé M
Brain Pathol; 2005 Apr; 15(2):101-8. PubMed ID: 15912881
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in desminopathies and myotilinopathies: a link between oxidative damage and abnormal protein aggregation.
Janué A; Olivé M; Ferrer I
Brain Pathol; 2007 Oct; 17(4):377-88. PubMed ID: 17784878
[TBL] [Abstract][Full Text] [Related]
10. Differential involvement of sarcomeric proteins in myofibrillar myopathies: a morphological and immunohistochemical study.
Claeys KG; van der Ven PF; Behin A; Stojkovic T; Eymard B; Dubourg O; Laforêt P; Faulkner G; Richard P; Vicart P; Romero NB; Stoltenburg G; Udd B; Fardeau M; Voit T; Fürst DO
Acta Neuropathol; 2009 Mar; 117(3):293-307. PubMed ID: 19151983
[TBL] [Abstract][Full Text] [Related]
11. Different early pathogenesis in myotilinopathy compared to primary desminopathy.
Fischer D; Clemen CS; Olivé M; Ferrer I; Goudeau B; Roth U; Badorf P; Wattjes MP; Lutterbey G; Kral T; van der Ven PF; Fürst DO; Vicart P; Goldfarb LG; Moza M; Carpen O; Reichelt J; Schröder R
Neuromuscul Disord; 2006 Jun; 16(6):361-7. PubMed ID: 16684602
[TBL] [Abstract][Full Text] [Related]
12. Desmin is oxidized and nitrated in affected muscles in myotilinopathies and desminopathies.
Janué A; Odena MA; Oliveira E; Olivé M; Ferrer I
J Neuropathol Exp Neurol; 2007 Aug; 66(8):711-23. PubMed ID: 17882015
[TBL] [Abstract][Full Text] [Related]
13. New insights into the protein aggregation pathology in myotilinopathy by combined proteomic and immunolocalization analyses.
Maerkens A; Olivé M; Schreiner A; Feldkirchner S; Schessl J; Uszkoreit J; Barkovits K; Güttsches AK; Theis V; Eisenacher M; Tegenthoff M; Goldfarb LG; Schröder R; Schoser B; van der Ven PF; Fürst DO; Vorgerd M; Marcus K; Kley RA
Acta Neuropathol Commun; 2016 Feb; 4():8. PubMed ID: 26842778
[TBL] [Abstract][Full Text] [Related]
14. Target genes of neuron-restrictive silencer factor are abnormally up-regulated in human myotilinopathy.
Barrachina M; Moreno J; Juvés S; Moreno D; Olivé M; Ferrer I
Am J Pathol; 2007 Oct; 171(4):1312-23. PubMed ID: 17823282
[TBL] [Abstract][Full Text] [Related]
15. Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis.
Ferrer I; Martín B; Castaño JG; Lucas JJ; Moreno D; Olivé M
J Neuropathol Exp Neurol; 2004 May; 63(5):484-98. PubMed ID: 15198127
[TBL] [Abstract][Full Text] [Related]
16. Pathological consequences of VCP mutations on human striated muscle.
Hübbers CU; Clemen CS; Kesper K; Böddrich A; Hofmann A; Kämäräinen O; Tolksdorf K; Stumpf M; Reichelt J; Roth U; Krause S; Watts G; Kimonis V; Wattjes MP; Reimann J; Thal DR; Biermann K; Evert BO; Lochmüller H; Wanker EE; Schoser BG; Noegel AA; Schröder R
Brain; 2007 Feb; 130(Pt 2):381-93. PubMed ID: 16984901
[TBL] [Abstract][Full Text] [Related]
17. Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers.
Weihl CC; Pestronk A
Curr Opin Neurol; 2010 Oct; 23(5):482-8. PubMed ID: 20664349
[TBL] [Abstract][Full Text] [Related]
18. Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis.
Güttsches AK; Brady S; Krause K; Maerkens A; Uszkoreit J; Eisenacher M; Schreiner A; Galozzi S; Mertens-Rill J; Tegenthoff M; Holton JL; Harms MB; Lloyd TE; Vorgerd M; Weihl CC; Marcus K; Kley RA
Ann Neurol; 2017 Feb; 81(2):227-239. PubMed ID: 28009083
[TBL] [Abstract][Full Text] [Related]
19. Protein aggregation in inclusion body myositis, a sporadic form among protein aggregate myopathies, and in myofibrillar myopathies--a comparative study.
Bastian A; Goebel HH
Rom J Intern Med; 2010; 48(4):377-84. PubMed ID: 21528768
[TBL] [Abstract][Full Text] [Related]
20. T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.
Hiniker A; Daniels BH; Margeta M
J Neuropathol Exp Neurol; 2016 Mar; 75(3):239-45. PubMed ID: 26843609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
